PT  - JOURNAL ARTICLE
AU  - Skylar W. Marvel
AU  - John S. House
AU  - Matthew Wheeler
AU  - Kuncheng Song
AU  - Yihui Zhou
AU  - Fred A. Wright
AU  - Weihsueh A. Chiu
AU  - Ivan Rusyn
AU  - Alison Motsinger-Reif
AU  - David M. Reif
TI  - The COVID-19 Pandemic Vulnerability Index (PVI) Dashboard: monitoring county level vulnerability
AID  - 10.1101/2020.08.10.20169649
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.10.20169649
4099  - http://medrxiv.org/content/early/2020/08/20/2020.08.10.20169649.short
4100  - http://medrxiv.org/content/early/2020/08/20/2020.08.10.20169649.full
AB  - While the COVID-19 pandemic presents a global challenge, the U.S. response places substantial responsibility for both decision-making and communication on local health authorities. To better support counties and municipalities, we integrated baseline data on relevant community vulnerabilities with dynamic data on local infection rates and interventions into a Pandemic Vulnerability Index (PVI). The PVI presents a visual synthesis of county-level vulnerability indicators that can be compared in a regional, state, or nationwide context. We describe use of the PVI, supporting epidemiological modeling and machine-learning forecasts, and deployment of an interactive, web Dashboard. The Dashboard facilitates decision-making and communication among government officials, scientists, community leaders, and the public to enable more effective and coordinated action to combat the pandemic.One Sentence Summary The COVID-19 Pandemic Vulnerability Index Dashboard monitors multiple data streams to communicate county-level trends and vulnerabilities and support local decision-making to combat the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by P42 ES027704, P30 ES029067, and P30 ES025128 and by intramural funds from the National Institute of Environmental Health Sciences.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There is no human data involved. All data is publicly available.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is publicly available at https://github.com/COVID19PVI/data https://covid19pvi.niehs.nih.gov/